TCTR20201111003进行中（未招募）2 期
THE EFFICACY AND SAFETY OF EPIDERMALGROWTH FACTOR COMBINED WITH FRACTIONALCARBON DIOXIDE LASER FOR ACNE SCARTREATMENT: A SPLIT-FACE TRIA
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •1. Healthy males and females between 18 to 50 years old.
- •2. Fitzpatrick skin Types III to V
- •3. Patients who have Goodman and Baron grading II-IV atrophic acne
排除标准
- •1. Pregnant or lactating woman.
- •2. Patients who have a history of keloid or hypertrophic scar formation.
- •3. Patients who have active facial acne or any active facial inflammation.
- •4. Patients who had been taking oral isotretinoin within the preceding 6
- •5. Patients who had been taking ablative laser within the preceding 6
- •6. Patients who had been taking nonablative laser within the preceding
- •7. Patients who have diabetes mellitus.
- •8. Patients who have collagen vascular disease.
- •9. Patients who have history of skin cancer.
- •10. Patients who have history of herpes labialis.
- •11. Patients who have allergic history to topical EGF or ingredients of
- •12. Patients who have allergic history to topical anesthetic cream.
研究者
相似试验
已完成
2 期
The effectiveness of an epidermal growth factor containing cream on postinflammatory hyperpigmentation after 1064 nm Q-switched Nd:YAG laser treatment of Hori nevus in AsiansPostinflammatory hyperpigmentationParticipants with symmetrical Hori nevusEpidermal growth factor1,064-nm Q-switched Nd:YAG laserHori nevusTCTR20210301001Division of Dermatology Ramathibodi hospital30
招募中
不适用
A study to test the efficacy of local application of epidermal growth factor in the treatment of non-healing ear drum perforationsCTRI/2012/03/002493KARNATAKA INSTITUTE OF MEDICAL SCIENCES60
已完成
不适用
The effects of epidermal growth factor receptor inhibition on pulmonary arterial hypertension associated with systemic sclerosisSclerosis-associated Pulmonary Arterial Hypertension (SScPAH)Circulatory SystemPulmonary Arterial HypertensionISRCTN75611179VU University Medical Centre (The Netherlands)20
暂停
2 期
Panitumumab as second line therapy for advanced pancreatic ductal adenocarcinoma with wild-type KRAS geneKRAS wild-type unresectable or metastatic pancreatic ductal adenocarcinomaCancer - PancreaticACTRN12617000540314Dr Daniel Croagh24
终止
2 期
Treatment of dry, age-related macular degeneration by epidermal growth factorISRCTN12733334fa Eye Research Institute7